The Nucleic Acid Labelling Market size in the Asia Pacific was valued at USD 242.99 Million in 2021. It is further projected to be growing at a CAGR of 9.9% and worth USD 389.56 Million by 2026.
Nucleic Acid Labelling has many applications in the fields of drug discovery and identification of new diseases. DNA and RNA are the information-carrying Nucleic acids that are of great significance for protein synthesis. They can be labeled with tags that assist in detection and purification processes. One of the labeling techniques is Nick Translation. Some of the nucleotides of a DNA sequence with their labeled analogs create a tagged DNA sequence used to probe fluorescent in situ hybridization blotting techniques. It can also be used for radiolabelling. DNA labeling has various applications in diagnosis and biotechnology.
The market's primary driving forces are increasing funding for R&D in genomics and disease diagnosis, increasing expenditure for health care, and increasing demand for personalized healthcare.
But, factors like expensive processing techniques and lack of skilled professionals are likely to hinder the market's growth.
This research report on the Asia Pacific Nucleic Acid Labelling Market has been segmented and sub-segmented into the following categories:
By Product:
By Labelling Technique:
By Application:
By End Users:
By Country:
Geographically, In Asia Pacific (APAC) Nucleic Acid Labelling Market, the rise in personalized medicine and the identification of GMOs and therapeutic will drive this market area's growth during the forecast period. It is further anticipated that emerging markets, such as China and Brazil, will achieve significant growth by the end of the forecast period.
The Asia Pacific is attributed to the prolongation of chronic diseases such as cancer, the aging of the population, the growing demand for targeted, personalized medicine, and aggressive government initiatives. In recent years, the government has launched initiatives that complement the APAC nucleic acid labeling market's growth. For example, the Precision Medicine Program's introduction in 2015 revolutionized the treatment of chronic diseases, which has accelerated nucleic acid labeling and acceptance in the region. India is foreseen to be another promising area in the APAC nucleic acid labeling market.
Companies playing a dominating role in the Asia Pacific Nucleic Acid Labelling Market include Thermo Fisher Scientific, New England Biolabs, PerkinElmer, F. Hoffmann La-Roche AG, General Electric Company, Merck KGaA, Enzo Biochem, Promega Corporation, Vector Laboratories, and Agilent Technologies.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Reagents and Kits
5.1.2.1 Labels
5.1.2.1.1 Radioactive Labels
5.1.2.1.2 Non-Radioactive Labels
5.1.2.2 Probes
5.1.2.2.1 Radioactive Probes
5.1.2.2.2 Non-Radioactive Probes
5.1.3 Services
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Labelling Technique
5.2.1 Introduction
5.2.2 PCR
5.2.3 Nick Translation
5.2.4 Random Primer
5.2.5 In-Vitro Transcription
5.2.6 Reverse Transcription
5.2.7 End Labelling
5.2.8 Y-o-Y Growth Analysis, By Labelling Technique
5.2.9 Market Attractiveness Analysis, By Labelling Technique
5.2.10 Market Share Analysis, By Labelling Technique
5.3 Application
5.3.1 Introduction
5.3.2 DNA Sequencing
5.3.3 Polymerase Chain Reaction
5.3.4 Fluorescence in Situ Hybridization (FISH)
5.3.5 Microarrays
5.3.6 Blotting
5.3.7 In-Situ Hybridization
5.3.8 Other Applications
5.3.9 Y-o-Y Growth Analysis, By Application
5.3.10 Market Attractiveness Analysis, By Application
5.3.11 Market Share Analysis, By Application
5.4 End-Users
5.4.1 Introduction
5.4.2 Diagnostic Centres
5.4.3 Research Centres
5.4.4 Hospitals
5.4.5 Y-o-Y Growth Analysis, By End-Users
5.4.6 Market Attractiveness Analysis, By End-Users
5.4.7 Market Share Analysis, By End-Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Labelling Technique
6.1.3.4 By Application
6.1.3.5 By End-Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Labelling Technique
6.1.4.4 By Application
6.1.4.5 By End-Users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Labelling Technique
6.1.5.4 By Application
6.1.5.5 By End-Users
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 New England Biolabs
8.3 PerkinElmer
8.4 F.Hoffmann La-Roche AG
8.5 General Electric Company
8.6 Merck KGaA
8.7 Enzo Biochem
8.8 Promega Corporation
8.9 Vector Laboratories
8.10 Agilent Technologies
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
